LY6G6D Protein (AA 20-104) (His-Strep-II Tag)
-
- Target Alle LY6G6D Proteine anzeigen
- LY6G6D (Lymphocyte Antigen 6 Complex, Locus G6D (LY6G6D))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 20-104
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses LY6G6D Protein ist gelabelt mit His-Strep-II Tag.
- Verwendungszweck
- Human LY6G6D Protein
- Sequenz
- Asn20-Ser104
- Produktmerkmale
- Recombinant Human LY6G6D Protein is expressed from HEK293 with His tag and Strep-II tag at the C-Terminus.It contains Asn20-Ser104.
- Reinheit
- > 95 % as determined by Tris-Bis PAGE
- Sterilität
- 0.22 μm filtered
- Endotoxin-Niveau
- Less than 1EU per μg by the LAL method.
- Top Product
- Discover our top product LY6G6D Protein
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- LY6G6D (Lymphocyte Antigen 6 Complex, Locus G6D (LY6G6D))
- Andere Bezeichnung
- LY6G6D (LY6G6D Produkte)
- Synonyme
- C6orf23 Protein, G6D Protein, LY6-D Protein, MEGT1 Protein, NG25 Protein, A930024F17Rik Protein, G6d Protein, G6f Protein, NG32 Protein, Ly6-D Protein, Ng25 Protein, lymphocyte antigen 6 family member G6D Protein, lymphocyte antigen 6 complex, locus G6D Protein, LY6G6D Protein, Ly6g6d Protein
- Hintergrund
- LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy.
- Molekulargewicht
- 12.33 kDa. Due to glycosylation, the protein migrates to 15-20 kDa based on Tris-Bis PAGE result.
- UniProt
- O95868
-